Maxivalen

Olive Oil, Refined, Soya-Bean Oil Refined, Triglycerides, Medium Chain, Fish Oil, Rich In Omega-3-Ac, the active ingredient in Maxivalen, is a parenteral lipid emulsion presented as an unknown/unknown for intravenous use. It provides calories and essential fatty acids for patients unable to tolerate enteral feeding.

GNH USA supplies Maxivalen as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals worldwide.

Maxivalen is used in the context of parenteral nutrition to supply energy and essential fatty acids to patients who cannot receive enteral feeding. - Parenteral nutrition: supplies caloric energy and essential fatty acids for patients unable to tolerate oral or tube feeding. - Critical care: supports metabolic demands of intensive care patients when enteral routes are contraindicated. - Post‑operative care: maintains nutritional status in surgical patients with delayed gastrointestinal function.

Adverse reactions may occur with any intravenous lipid emulsion. Monitoring and appropriate management are essential.

Common Side Effects: - Hypertriglyceridemia: elevated serum triglyceride levels during therapy. - Fever or chills: transient temperature rise during infusion. - Infusion site erythema: redness or irritation at the catheter site. - Mild hepatic enzyme elevation: temporary increase in liver function tests.

Serious or Rare Side Effects: - Fat overload syndrome: severe metabolic disturbance with high triglycerides and hepatic dysfunction. - Acute respiratory distress: rare pulmonary complications linked to lipid emboli. - Anaphylactoid reaction: severe hypersensitivity requiring immediate medical intervention.

Prior to initiating Maxivalen, clinicians should assess patient-specific risk factors and monitor relevant parameters. - Monitor triglyceride levels: check serum triglycerides regularly to avoid hypertriglyceridemia. - Assess liver function: periodic liver enzyme tests are recommended. - Evaluate for fat overload syndrome: watch for signs of metabolic imbalance. - Use aseptic technique: ensure sterile handling of the infusion set and solution. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Maxivalen may interact with other agents that affect lipid metabolism or coagulation.

Major Interactions (Avoid): - Concurrent lipid emulsions: risk of cumulative fat load. - Propofol infusion: additive hypertriglyceridemia potential. - High‑dose heparin therapy: may exacerbate triglyceride elevation.

Moderate Interactions (Monitor Closely): - Warfarin: possible alteration of vitamin K‑dependent clotting factors. - Certain antibiotics (e.g., ceftriaxone): increased risk of phlebitis. - Systemic corticosteroids: may raise serum lipid concentrations.